Hydrocortisone sodium succinate Good Manufacturer supply High Quality 125-04-2
- Molecular Formula:C25H33NaO8
- Molecular Weight:502.59
- Vapor Pressure:9.36E-22mmHg at 25°C
- Melting Point:169.0-171.2°
- Boiling Point:685.5 °C at 760 mmHg
- Flash Point:231.1 °C
- PSA：141.03000
- LogP:0.86260
Hydrocortisone sodium succinate (125-04-2) Usage
Hydrocortisone sodium succinate, also known as Hydrocortisone Hemisuccinate Sodium, is a water-soluble derivative of the glucocorticoid Hydrocortisone (H714615). It is a pharmaceutical compound that exhibits anti-inflammatory and immunosuppressive properties by binding to glucocorticoid receptors and initiating the transcription of relevant mediators. Hydrocortisone sodium succinate is also used to supplement media for long-term epithelial or endothelial cell cultures and to differentiate pluripotent stem cells.
How to get the best price on Hydrocortisone sodium succinate?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Hydrocortisone sodium succinate . You can buy high quality, low price Hydrocortisone sodium succinate 125-04-2 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
